Free Republic

Monoclonal antibody treatment can reduce the severity of COVID-19 if infused quickly after a positive test. That’s been in the books for months, even though it doesn’t draw much attention. Now anyone considered high risk, who is exposed to COVID-19, qualifies for the treatment, adding the preventative capability into the mix. “We know from previous data that we can reduce the need for hospitalization and the risk of dying by 70% if we can get the medication in on time,’’ said Dr. Bruce Muma, CEO of the Henry Ford Physician Network who heads up Henry Ford’s monoclonal antibody program. “...

Huntsville Memorial Hospital is the latest to start offering COVID-19 monoclonal antibody infusion treatments. As the number of COVID-19 hospitalizations continues to rise across the state, more treatments and resources are becoming available for those who contract the virus. Dr. Sujesh Pillai is the chief of staff for Huntsville Memorial. He says they’ve administered a little over 50 infusions in the last two weeks, and only one person had to be admitted to the hospital. “When you get the infusion treatment, it’s a one-hour IV infusion that we do in the hospital. You’re not admitted. You go home right after...

Daily Trends in Number of COVID-19 Deaths in Florida Reported to CDC

A new COVID-19 antibody treatment center has opened in Fort Worth, Texas. On Wednesday, Texas Chief Epidemiologist Dr. Jennifer Shuford said the monoclonal antibody treatment would be offered to a wide variety of people. The treatment, known as Regeneron, was used by both President Trump and Texas Gov. Greg Abbott (R) when they tested positive for COVID-19. The treatment would be available for free at the newly opened center. Various other centers have opened in the state of Texas. Abbott announced a new opening in Nacogdoches was set for Friday morning.

Republican Florida Gov. Ron DeSantis shot back at The Associated Press on Monday after the outlet's incoming CEO accused his press secretary of harassing one of its reporters, saying the AP received deserved pushback for a partisan "smear" that could cost lives. In a letter to Daisy Veerasingham, DeSantis blasted the AP for its "temerity" to complain about criticism a reporter received last week over his story that suggested a link between the governor's touting of a COVID antibody drug from Regeneron and a political donor's investment in the company. DeSantis didn't hold back in a remarkable open letter from...

A Covid antibody cocktail drug used to treat former US President Donald Trump has finally been approved for UK patients. Britain's medical regulator gave Ronapreve the green light after a major UK study found it could prevent prevent infection and treat patients who were already sick. It showed that among patients with at least one risk factor for severe Covid, it slashed their risk of death or hospitalisation by 70 per cent. ,,, ...The drug has also been shown to dramatically reduced the risk of catching Covid, but protection only lasts for a month. UK health officials will now decide...

Infusion center locator. To find a Center for Monoclonal infusion therapy. https://covid.infusioncenter.org

Is REGEN-COV the answer to COVID? Nearly a year and a half has passed and over 618,000 COVID-19 related deaths were recorded in the U.S. alone and finally the FDA released an emergency use authorization for REGEN-COV; a new drug that was undergoing testing in 2020 (pre-Biden). It is now an early treatment option for primary care physicians. Until this point, the only authorized COVID-19 treatment my family doctor had per the July 2021 update to NIH guidelines was recommend quarantine, wait until symptoms go away or report to a hospital if they get worse. It is noteworthy that these...

Texas Gov. Abbott has tested positive for COVID-19 Texas Governor Greg Abbott has tested positive for Covid-19, according to a statement from his office.Mark Miner, the communications director of Texas Governor Abbot, issued a statement Tuesday afternoon saying the governor is tested for the virus daily and that on Tuesday he had a positive result.Statement:“Office of the Governor Communications Director Mark Miner today issued a statement after Governor Greg Abbott tested positive for COVID-19: “Governor Greg Abbott today tested positive for the COVID-19 virus. The Governor has been testing daily, and today was the first positive test result. Governor Abbott...

"Governor Abbott is in constant communication with his staff, agency heads, and government officials to ensure that state government continues to operate smoothly and efficiently," his office said. Abbott is receiving Regeneron's monoclonal antibody treatment and plans to isolate in the Governor's Mansion. His wife Cecilia Abbott tested negative.

**HERE'S WHAT WAS SHARED IN ANOTHER MEWE FORUM** : **This is very useful Life Saving information for those in the USA.** *Monoclonal Antibodies are one of the best therapies for those with Covid. President Trump himself was injected with Regeneron monoclonals and was released from Walter Reed Hospital in a few days, ready to resume his job.* *Here are the Hospitals in the USA that have received shipments of monoclonal antibody therapeutics.* *Punch in your city or ZIP Code to see if a hospital near you offers this therapeutic. Apparently, this therapeutic is available in all 50 states.* https://protect-public.hhs.gov/pages/therapeutics-distribution#distribution-locations

The U.S. Food and Drug Administration has expanded the emergency use authorization of Regeneron Pharmaceuticals Inc's (REGN.O) COVID-19 antibody cocktail, enabling its use as a preventive treatment for the illness in certain people.

The UK RECOVERY trial investigators recently disclosed that Regeneron’s REGEN-COV, a pair of monoclonal antibodies, actually reduced the risk of death by 20% in patients hospitalized with COVID-19 who failed to sustain their own immune response. According to the company’s press release, this monoclonal antibody cocktail represents the first antibody treatment that improved survival in patients hospitalized with COVID-19. The company will not only share this data with regulatory authorities immediately but will also seek to expand its U.S. EUA to include appropriate hospitalized patients.TrialSite provides a brief summary breakdown of this most recent information generated by the UK RECOVERY...

Regeneron announced on Friday that the Food and Drug Administration (FDA) is allowing a lower dose of its CCP virus treatment for injection.The approval comes as an update to the FDA’s emergency use authorization (EUA) for the company’s antibody cocktail to treat COVID-19, the disease caused by the CCP (Chinese Communist Party) virus. The treatment has been available under the EUA since last November for those recently diagnosed with COVID-19.The FDA had in November authorized a 2,400 mg dose of the antibody cocktail REGEN-COV—a combination of the monoclonal antibodies casirivimab and imdevimab—to be administered as a single dose directly injected...

“With more than 60,000 Americans continuing to be diagnosed with COVID-19 every day, the REGEN-COV antibody cocktail may help provide immediate protection to unvaccinated people who are exposed to the virus,” Dr. George Yancopoulos, president and chief scientific officer at Regeneron, said in a press release.

Regeneron's cocktail, a mixture of two drugs, imitates antibodies that the body generates when fighting the coronavirus in order to boost the immune system The antibody treatment was authorized by the FDA to treat mild to moderate cases of COVID-19 in November Half a group of 4,500 mild-to-moderate COVID-19 patients at high risk of severe illness were given one of two doses of the drugs Both doses were found to reduce the risk of hospitalization or death by about 70% compared to a placebo Recovery time was also shortened, with symptoms only lasting about 10 days in the cocktail group...

New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, or at high risk for SARS-CoV-2 infection, could move the needle on clinician acceptance of the treatments, experts say. Two monoclonal antibody formulations, Eli Lilly's bamlanivimab and Regeneron's cocktail of two antibodies, casirivimab and imdevimab, received emergency use authorizations from the US Food and Drug Administration in November to treat mild to moderate COVID-19 in outpatients. But current recommendations from the Infectious Diseases Society of America's COVID-19 treatment and guideline panel, based on data from a phase 2 trial of bamlanivimab, suggest against the routine...

Question for all FReepers, especially those with a medical background:Why are people continuing to die from (or more likely WITH) Covid when there are therapeutics available? PDJT had it, got over it, and credited a drug called Regeneron with his recovery, calling it nothing short of a 'cure'.Yet we continue to wring are hands over the availability of a 'vaccine' that may or may not be effective.Ok, I know the politics behind this -- if Trump says positive things about it, the 'Rats and the media -- but I repeat myself -- immediately pooh-pooh it. IMO, any politician who withholds...

RUDY Giuliani has insisted that "you can overdo" face masks as he remains hospitalized with coronavirus and awaits his release after taking the drug Remdesivir. Donald Trump's personal lawyer called into his own radio show from the hospital on Tuesday to update listeners on his current bill of health. "Pretty much all the symptoms are gone now," the attorney said, saying that he's "doing fine" and is taking the drug Remdesivir, the same experimental drug Trump took during his own battle with Covid in October. Giuliani revealed that he'll be released from George Washington University hospital on Wednesday in Washington...

The U.S. government will start distributing Regeneron Pharmaceuticals' newly authorized COVID-19 antibody combination on Tuesday, beginning with over 30,000 treatment courses, a health official said on Monday... ...U.S. officials on a call with reporters said doses will be allocated based on which states have the highest numbers of confirmed cases and hospitalizations... ...Regeneron has said it expects to have enough REGEN-COV2 for about 80,000 patients by the end of this month. It expects to have enough doses to treat about 200,000 patients by the first week of January, rising to some 300,000 patients in total by ...